Eusa Pharma (Uk) Limited
United KingdomFDA 510(k) applicant, unverified
- Devices
- 4
What Eusa Pharma (Uk) Limited makes
Eusa Pharma (UK) Limited manufactures oral artificial saliva products, including Caphosol® Artificial Saliva Tablets and Caphosol® Artificial Saliva in 32-dose sachet boxes. These products are designed to relieve dry mouth symptoms by providing lubrication and hydration to oral tissues.
The company’s portfolio is classified under FDA device class U and is listed via 510(k) clearance in the United States. The manufacturer is based in the UK but operates within the US regulatory framework.
Catalogue
- GUDID
- GUDID
Caphosol Artifical Saliva Tablets Ref K162167
510(k) 510(k)Caphosol® Artifical Saliva (32 doses sachet box) Ref K234015
510(k) 510(k)
Company details
- DUNS number
- 220512050
Frequently asked questions
How many devices does Eusa Pharma (Uk) Limited have in the registry?
The registry currently lists 4 devices for Eusa Pharma (Uk) Limited. Devices recorded under merged duplicate company entries are counted once.
Which registries list Eusa Pharma (Uk) Limited's devices?
Among its 4 most recently registered devices, Eusa Pharma (Uk) Limited has devices listed in FDA 510(k) (2 devices) and FDA GUDID (2 devices). A device can be listed in more than one registry, so these counts overlap.
What are the newest devices from Eusa Pharma (Uk) Limited in the registry?
The most recently registered devices listed for Eusa Pharma (Uk) Limited include Caphosol 64 x 15 mL ampules aqueous solution, Caphosol® Artifical Saliva 64 x 15 mL sachets aqueous solution, Caphosol Artifical Saliva Tablets and Caphosol® Artifical Saliva (32 doses sachet box).